RadNet Cost of Goods Sold 2010-2024 | RDNT

RadNet cost of goods sold from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
RadNet Annual Cost of Goods Sold
(Millions of US $)
2023 $1,395
2022 $1,264
2021 $1,123
2020 $966
2019 $1,000
2018 $868
2017 $802
2016 $776
2015 $708
2014 $603
2013 $599
2012 $543
2011 $478
2010 $421
2009 $398
RadNet Quarterly Cost of Goods Sold
(Millions of US $)
2024-06-30 $390
2024-03-31 $388
2023-12-31 $357
2023-09-30 $342
2023-06-30 $345
2023-03-31 $352
2022-12-31 $330
2022-09-30 $314
2022-06-30 $306
2022-03-31 $315
2021-12-31 $285
2021-09-30 $273
2021-06-30 $284
2021-03-31 $282
2020-12-31 $258
2020-09-30 $246
2020-06-30 $194
2020-03-31 $267
2019-12-31 $256
2019-09-30 $254
2019-06-30 $247
2019-03-31 $243
2018-12-31 $233
2018-09-30 $209
2018-06-30 $210
2018-03-31 $216
2017-12-31 $200
2017-09-30 $198
2017-06-30 $199
2017-03-31 $205
2016-12-31 $192
2016-09-30 $193
2016-06-30 $194
2016-03-31 $197
2015-12-31 $188
2015-09-30 $176
2015-06-30 $176
2015-03-31 $169
2014-12-31 $157
2014-09-30 $153
2014-06-30 $148
2014-03-31 $145
2013-12-31 $149
2013-09-30 $152
2013-06-30 $149
2013-03-31 $150
2012-12-31 $138
2012-09-30 $133
2012-06-30 $137
2012-03-31 $135
2011-12-31 $125
2011-09-30 $118
2011-06-30 $119
2011-03-31 $116
2010-12-31 $109
2010-09-30 $107
2010-06-30 $106
2010-03-31 $99
2009-12-31 $99
2009-09-30 $102
2009-06-30 $100
2009-03-31 $97
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $4.963B $1.617B
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.379B 12.93
Quest Diagnostics (DGX) United States $17.308B 17.75
DaVita (DVA) United States $13.689B 16.84
Encompass Health (EHC) United States $9.303B 22.88
Chemed (CHE) United States $8.694B 26.73
Elanco Animal Health (ELAN) United States $7.242B 16.28
Option Care Health (OPCH) United States $5.321B 26.14
Amedisys (AMED) United States $3.181B 22.75
Astrana Health (ASTH) United States $2.805B 39.69
LifeStance Health (LFST) United States $2.579B 0.00
Addus HomeCare (ADUS) United States $2.399B 29.12
U.S Physical Therapy (USPH) United States $1.274B 34.50
Pennant (PNTG) United States $1.057B 50.71
Aveanna Healthcare Holdings (AVAH) United States $1.022B 0.00
Atai Life Sciences (ATAI) Germany $0.208B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.025B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.010B 0.00
Novo Integrated Sciences (NVOS) United States $0.006B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00